These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2480492)

  • 1. Present use of positive inotropic drugs in heart failure.
    Schlepper M; Thormann J; Kremer P; Mitrovic V; Kramer W
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S9-19. PubMed ID: 2480492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Positive inotropic substances--therapeutic perspectives].
    Erdmann E; Böhm M
    Z Kardiol; 1991; 80 Suppl 8():57-62. PubMed ID: 1796636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inodilator therapy for heart failure. Early, late, or not at all?
    Remme WJ
    Circulation; 1993 May; 87(5 Suppl):IV97-107. PubMed ID: 8097971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of the phosphodiesterase III inhibitor in ischemic heart disease].
    Schlepper M; Mitrovic V; Thormann J
    Z Kardiol; 1991; 80 Suppl 4():75-83. PubMed ID: 1926997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of chronic heart failure with positive inotropic agents].
    Lechat P
    Therapie; 1989; 44(6):437-45. PubMed ID: 2576155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some new positive inotropic agents.
    Andersson KE
    Acta Med Scand Suppl; 1986; 707():65-73. PubMed ID: 2874692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of phosphodiesterase inhibitors in anesthesia and intensive care].
    Boldt J; Hammermann H; Hempelmann G
    Z Kardiol; 1994; 83 Suppl 2():75-82. PubMed ID: 8091829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodynamic effects of enoximone--comparative studies of heart surgery patients].
    Boldt J; Hempelmann G
    Z Kardiol; 1991; 80 Suppl 4():41-6. PubMed ID: 1833896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New positive inotropic drugs in acute and chronic heart failure].
    Follath F
    Schweiz Rundsch Med Prax; 1992 May; 81(21):704-7. PubMed ID: 1351309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of new inotropic agents on exercise performance.
    Weber KT; Janicki JS; Maskin CS
    Circulation; 1986 Mar; 73(3 Pt 2):III196-204. PubMed ID: 2867837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacotherapy of severe heart failure with inodilators--new approaches].
    Baumann G; Hader O
    Z Kardiol; 1996; 85 Suppl 4():9-19. PubMed ID: 9027110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic, anti-ischemic, metabolic and neurohumoral effects of enoximone (MDL 17,043) in patients with coronary disease].
    Mitrovic V; Schlepper M; Neuzner J; Bahavar H; Volz M; Dieterich HA
    Z Kardiol; 1988 Oct; 77(10):660-7. PubMed ID: 2977029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of three phosphodiesterase type III inhibitors on mechanical and metabolic function in guinea pig isolated hearts.
    Zausig YA; Stowe DF; Zink W; Grube C; Martin E; Graf BM
    Anesth Analg; 2006 Jun; 102(6):1646-52. PubMed ID: 16717301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enoximone as an alternative to mechanical circulatory support prior to heart transplantation].
    Schmid ER; Zollinger A; Turina M; Dieterich HA
    Schweiz Med Wochenschr; 1989 Sep; 119(36):1231-6. PubMed ID: 2529633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of the positive inotropic effect of phosphodiesterase inhibitors].
    Scholz H; Dieterich HA; Schmitz W
    Z Kardiol; 1991; 80 Suppl 4():1-6. PubMed ID: 1656618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energetic consequences of substances currently used or recommended for long-term treatment of chronic heart failure.
    Holubarsch C; Hasenfuss G; Thierfelder L; Just H
    Basic Res Cardiol; 1991; 86 Suppl 1():107-12. PubMed ID: 1827977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of inodilators.
    Dei Cas L; Metra M; Visioli O
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S60-71. PubMed ID: 2483442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency].
    Richard C; Thuillez C; Annane D; Bellissant E; Teboul JL
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():33-7. PubMed ID: 2147832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.